Login / Signup

Dual-energy x-ray absorptiometry assessment of bone health in Australian men with prostate cancer commencing androgen deprivation therapy.

Mariya F HamidAmy HaydenTania MoujaberSandra TurnerHoward GurneyMathis GrossmannPeter Wong
Published in: The Medical journal of Australia (2023)
For about 80% of men with prostate cancer commencing ADT in Australia, therapy initiation was not accompanied by DXA assessment of bone health. Given the excellent long term prognosis for men with prostate cancer and the availability of bone protective therapy, bone health monitoring should be a routine component of prostate cancer care for men receiving ADT.
Keyphrases